| Ashley Lynn Nelson, | |
|
111 E Lanyon St, Frontenac, KS 66763-2428 | |
| (620) 687-3636 | |
| Not Available |
| Full Name | Ashley Lynn Nelson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 111 E Lanyon St, Frontenac, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750066783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 13-108731-021 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Lynn Nelson, 111 E Lanyon St, Frontenac, KS 66763-2428 Ph: (620) 687-3636 | Ashley Lynn Nelson, 111 E Lanyon St, Frontenac, KS 66763-2428 Ph: (620) 687-3636 |
News Archive
A study led by Dr Emma Sweeney and Adjunct Associate Professor Christine Knox, from QUT's Institute of Health and Biomedical Innovation, with colleagues at the University of Queensland, showed that the growth of some microbes was inhibited for up to 24 hours following breastmilk and saliva mixing.
Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).
Bioinformaticians at IMIM (Hospital del Mar Medical Research Institute) and UPF (Pompeu Fabra University) have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, i.e., how newly formed inert virus particles become infectious, which is essential in understanding how the virus replicates.
Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia.
› Verified 9 days ago